Literature DB >> 13211803

Studies on copper metabolism. XIII. Hepatolenticular degeneration.

G E CARTWRIGHT, R E HODGES, C J GUBLER, J P MAHONEY, K DAUM, M M WINTROBE, W B BEAN.   

Abstract

Entities:  

Keywords:  COPPER/metabolism; HEPATOLENTICULAR DEGENERATION/metabolism in

Mesh：

Substances：

Year:  1954        PMID： 13211803      PMCID： PMC1072574          DOI： 10.1172/JCI103027

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  26 in total

1.  Metabolism of copper in hepatolenticular degeneration.

Authors:  W T ZIMDAHL; I HYMAN; E D COOK
Journal:  Neurology       Date:  1953-08       Impact factor: 9.910

2.  The metabolic disorder in hepato-lenticular degeneration.

Authors:  W B MATTHEWS; M D MILNE; M BELL
Journal:  Q J Med       Date:  1952-10

3.  Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol).

Authors:  J F PALMER; A L DREW; M B CHENOWETH
Journal:  Med Bull (Ann Arbor)       Date:  1953-11

4.  Cobalt, copper and molybdenum in the nutrition of animals and plants.

Authors:  H R MARSTON
Journal:  Physiol Rev       Date:  1952-01       Impact factor: 37.312

5.  The effects of B.A.L. in hepatolenticular degeneration.

Authors:  J N CUMINGS
Journal:  Brain       Date:  1951-03       Impact factor: 13.501

6.  Experimental Copper Poisoning.

Authors:  F B Mallory; F Parker
Journal:  Am J Pathol       Date:  1931-07       Impact factor: 4.307

7.  Copper excretion in the urine of normal individuals and of patients with hepatolenticular degeneration (Wilson's disease).

Authors:  H PORTER
Journal:  Arch Biochem Biophys       Date:  1951-04       Impact factor: 4.013

8.  Studies on copper metabolism. XI. Copper and iron metabolism in the nephrotic syndrome.

Authors:  G E CARTWRIGHT; C J GUBLER; M M WINTROBE
Journal:  J Clin Invest       Date:  1954-04       Impact factor: 14.808

9.  The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).

Authors:  D DENNY-BROWN; H PORTER
Journal:  N Engl J Med       Date:  1951-12-13       Impact factor: 91.245

10.  The familial nature of the amino-aciduria of Wilson's disease (hepatolenticular degeneration).

Authors:  L L UZMAN; B HOOD
Journal:  Am J Med Sci       Date:  1952-04       Impact factor: 2.378
View more
  31 in total

1.  Abnormalities of zinc and copper during total parenteral nutrition.

Authors:  S F Lowry; J T Goodgame; J C Smith; M M Maher; R W Makuch; R I Henkin; M F Brennan
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

2.  Copper and health.

Authors:  R L Koul
Journal:  Indian J Pediatr       Date:  1975-03       Impact factor: 1.967

3.  Wilson's disease.

Authors:  C B WARREN; P M BROUGHTON
Journal:  Arch Dis Child       Date:  1962-06       Impact factor: 3.791

4.  WILSON'S DISEASE PRESENTING AS AN ACUTE HAEMOLYTIC ANAEMIA.

Authors:  B M LAURANCE
Journal:  Proc R Soc Med       Date:  1965-08

5.  Wilson's disease. The presenting symptoms.

Authors:  J M WALSHE
Journal:  Arch Dis Child       Date:  1962-06       Impact factor: 3.791

6.  Effect of estrogens on copper metabolism in Wilson's disease.

Authors:  J L GERMAN; A G BEARN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

7.  [Disorders of transport processes as causes of diseases and of disease symptoms (based on examples of jaundice, hemochromatosis and Wilson's disease and of iron deficiency anemia)].

Authors:  H BENNHOLD
Journal:  Klin Wochenschr       Date:  1960-04-15

8.  Observations on ceruloplasmin in Wilson's disease.

Authors:  A SASS-KORTSAK; M CHERNIAK; D W GEIGER; R J SLATER
Journal:  J Clin Invest       Date:  1959-10       Impact factor: 14.808

9.  Liver disease.

Authors:  F W HOFFBAUER
Journal:  Am J Dig Dis       Date:  1959-10

10.  Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.

Authors:  J A BUSH; J P MAHONEY; H MARKOWITZ; C J GUBLER; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1955-12       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.